Michelle Cines
University of Maryland, Baltimore
7 Papers
52 Citations
Michelle Cines is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Heart failure & Placebo. The author has an hindex of 6, co-authored 7 publications. Previous affiliations of Michelle Cines include University of Maryland, College Park & United States Department of Veterans Affairs.
Chat about Author
Papers
Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease A Randomized Clinical Trial
Karl Kieburtz,Barbara C. Tilley,Jordan J. Elm,Debra Babcock,Robert A. Hauser,G. Webster Ross,Alicia H. Augustine,Erika U. Augustine,Michael J. Aminoff,Ivan Bodis-Wollner,James T. Boyd,Franca Cambi,Kelvin L. Chou,Chadwick W. Christine,Michelle Cines,Nabila Dahodwala,Lorelei Derwent,Richard B. Dewey,Katherine B. Hawthorne,David J. Houghton,Cornelia Kamp,Maureen A. Leehey,Mark F. Lew,Grace S. Liang,Sheng Luo,Zoltan Mari,John C. Morgan,Sotirios A. Parashos,Adriana Pérez,Helen Petrovitch,Suja S. Rajan,Sue Reichwein,Jessie Roth,Jay S. Schneider,Kathleen M. Shannon,David Simon,Tanya Simuni,Carlos Singer,Lewis Sudarsky,Caroline M. Tanner,Chizoba C. Umeh,Karen Williams,Anne-Marie Wills +42 more
TL;DR: Among patients with early and treated Parkinson disease, treatment with creatine monohydrate for at least 5 years, compared with placebo did not improve clinical outcomes, and these findings do not support the use of creatine mon carbohydrate in patients with Parkinson disease.
199
A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure
Stephen S. Gottlieb,Willem J. Kop,Sue A. Thomas,Scott Katzen,Mark R. Vesely,Nancy Greenberg,Joanne Marshall,Michelle Cines,Stacey Minshall +8 more
TL;DR: Antidepressant therapy with paroxetine CR results in significant reductions in depression among patients with heart failure, and these reductions are accompanied by improvements in psychological aspects of quality of life.
124
High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure
Stephen S. Gottlieb,David W. Riggio,Salvatore S. Lauria,Robert W. Peters,Stephen R. Shorofsky,Michelle Cines,Deborah Froman,Michael R. Gold +7 more
TL;DR: Although the first dose caused vasodilation, a complete loading regimen of amiodarone produced a decreased heart rate with elevated filling pressures and decreased cardiac index.
45
Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure.
TL;DR: The need to consider both rate of administration and the dosage when evaluating the safety and efficacy of a new class III antiarrhythmic drug is emphasized.
9
The hemodynamic actions of the antiarrhythmic agent ipazilide fumarate in patients with congestive heart failure
Stephen S. Gottlieb,Stephen S. Gottlieb,Michelle Cines,Michelle Cines,Michael D. Pressel,Michael D. Pressel +5 more
TL;DR: It is concluded that, as with most antiarrhythmic agents, single‐dose administration of ipazilide fumarate can cause clinically significant hemodynamic deterioration.
1